Product Description
FYGAB TOTAL GEL combines Gabapentin, Lidocaine Hydrochloride and Baclofen in a topical formulation. Gabapentin is associated with modulation of nerve signalling, Lidocaine provides local anaesthetic activity by blocking sodium channels, and Baclofen acts on GABA-B receptors to reduce neuronal excitability. The formulation brings together three different pharmacological actions in a gel base for topical application.
Target Speciality
- Pain Management
- Neurology
- Orthopaedics
Key Attributes
- Three-Component Combination: Brings together ingredients with different pharmacological actions.
- Neuromodulatory Component: Gabapentin acts on calcium-channel subunits involved in nerve signalling.
- Local Anaesthetic Component: Lidocaine helps inhibit nerve impulse conduction at the application site.
- GABA-B Receptor Activity: Baclofen acts through inhibitory GABA-B receptor pathways.
- Quality & Presentation: Manufactured under WHO-GMP standards and presented in premium-packaging, with a refined product appearance and packaging design.
Disclaimer
This information is for general reference only and does not replace professional medical advice. To be administered only under medical supervision. Not for public promotion.
Frequently Asked Questions
- Is monopoly available for FYGAB TOTAL GEL?
Yes. District-wise monopoly rights are offered across India. Tell us your district and we will confirm availability.
- What is the composition of FYGAB TOTAL GEL?
It contains Gabapentin 6% w/w, Lidocaine Hydrochloride 5.0% w/w, Baclofen IP 2.0% w/w, Methylparaben 0.10% w/w and Propylparaben IP 0.05% w/w.
- Is FYGAB TOTAL GEL manufactured at a WHO-GMP-certified facility?
Yes. Manufacturing follows GLP, WHO, ISO and GMP norms, and every batch is assayed for actual content before dispatch.
- What is the minimum order quantity (MOQ) for FYGAB TOTAL GEL?
The minimum order quantity may vary depending on the product and business requirements. Please contact our team for current MOQ and pricing details.










